Business News


Zimmer-Biomet-042414-lg.jpgZimmer Holdings, Inc., a manufacturer of orthopedic reconstructive, spinal and trauma devices, reported Thursday a higher profit in its first quarter with increased sales. Adjusted earnings topped analysts' estimates, while sales missed their view. Further, the company trimmed its forecast for fiscal 2014 earnings, and backed sales growth view.
More

Baxter Says FDA OKs ADVATE With BAXJECT III Reconstitution System - Quick Facts



Baxter International Inc. (BAX) said the U.S. Food and Drug Administration or FDA has approved a new reconstitution system for Antihemophilic Factor [Recombinant] or ADVATE. ADVATE and the diluent come pre-packaged in the new BAXJECT III reconstitution system. "ADVATE has the widest range of dosage...
More

Latest News
More

UnitedParcelService-042414.jpg

UPS Q1 Results Miss Forecast Amid Harsh Weather


Package delivery giant United Parcel Service Inc. (UPS) Thursday reported lower profit for the first quarter, amid a tepid growth in revenues, hit by the severe weather conditions. Both earnings and revenues missed Wall Street expectations and the company expects full year earnings per share to be at the low end of its previous projection.
More

Italy's March Non-EU Trade Surplus Grows


Italy's non-EU trade surplus in March increased from last year, data from the statistical office Istat showed Thursday. The trade surplus advanced to EUR 2.70 billion in March from EUR 2.53 billion last year. In February, the country logged a surplus of EUR 1.37 billion, while there was a deficit...
More

Great Lakes Sells Historical Demolition Business


NexJ Systems Announces Acquisition Of Liberate Ideas

Westcon Group Announces Intent To Acquire Intact Integrated Services

More

Lam Research Corp. (LRCX) Is Up Sharply After Q3 Profit Beat Expectations


Lam Research Corp. (LRCX) reported third quarter adjusted EPS of $1.26 after the bell Wednesday, which exceeded the consensus estimate of $1.17. The company expects to report fourth quarter adjusted EPS of 1.21 plus or minus $0.07 per share. Analysts are expecting EPS of $1.09. Lam Research gapped...
More

MCig's Subsidiary VitaCig Files For IPO - Quick Facts


mCig Inc. (MCIG.OB) announced that its wholly owned subsidiary VitaCig Inc. has filed a Form S-1 with the Securities and Exchange Commission or SEC for the registration of 250 million VitaCig shares that will be paid out to mCig shareholders as a dividend on the record date. The record date has now been...
More